Nerandomilast mechanism of action Back Related content Read more FIBRONEER-ILD™ Trial Study design Read more Read more The interplay of vasculopathy and fibrosis in SSc Infographic slide Read more Read more VITALISScE™ trial Infographic slide Read more Read more ANCHOR-RA: Risk factor-guided RA-ILD screening Infographic slide Read more Home APLAR congress Nerandomilast mechanism of action
